| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Channing Laboratory, Department of Medicine Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts 02115; and Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts 02115
Prostate cancer is the most common cancer in American men. Preventable measures for this malignancy are not well established. Among potentially beneficial natural compounds is the carotenoid lycopene, which is derived largely from tomato-based products. Recent epidemiologic studies have suggested a potential benefit of this carotenoid against the risk of prostate cancer, particularly the more lethal forms of this cancer. Five studies support a 30% to 40% reduction in risk associated with high tomato or lycopene consumption, three are consistent with a 30% reduction in risk, but the results were not statistically significant, and seven were not supportive of an association. The largest relevant dietary study, a prospective study in male health professionals found that consumption of two to four servings of tomato sauce per week was associated with about a 35% risk reduction of total prostate cancer and a 50% reduction of advanced (extraprostatic) prostate cancer. Tomato sauce was by far the strongest predictor of plasma lycopene levels in this study. In the largest plasma-based study, very similar risk reductions were observed for total and advanced prostate cancer for the highest versus lowest quintile of lycopene. Other studies, mostly dietary case-control studies, have not been as supportive of this hypothesis. The reasons for these inconsistencies are unclear, but in three of the seven null studies, tomato consumption or serum lycopene level may have been too low to observe an effect. Because the concentration and bioavailability of lycopene vary greatly across the various food items, dietary questionnaires vary markedly in their usefulness of estimating the true variation in tissue lycopene concentrations across individuals. To optimize the interpretation of future findings, the usefulness of the questionnaire to measure lycopene levels in a population should be directly assessed. Although not definitive, the available data suggest that increased consumption of tomatoes and tomato-based products may be prudent.
Key Words: lycopene • carotenoids • epidemiology • prostaticneoplasms
This article has been cited by other articles:
|
|
 |
|
  J. P. Mills, P. W. Simon, and S. A. Tanumihardjo Biofortified Carrot Intake Enhances Liver Antioxidant Capacity and Vitamin A Status in Mongolian Gerbils J. Nutr., September 1, 2008; 138(9): 1692 - 1698. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. V. Mossine, P. Chopra, and T. P. Mawhinney Interaction of Tomato Lycopene and Ketosamine against Rat Prostate Tumorigenesis Cancer Res., June 1, 2008; 68(11): 4384 - 4391. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Liu, J. D. Allen, J. T. Arnold, and M. R. Blackman Lycopene inhibits IGF-I signal transduction and growth in normal prostate epithelial cells by decreasing DHT-modulated IGF-I production in co-cultured reactive stromal cells Carcinogenesis, April 1, 2008; 29(4): 816 - 823. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Mills, P. W. Simon, and S. A. Tanumihardjo {beta}-Carotene from Red Carrot Maintains Vitamin A Status, but Lycopene Bioavailability Is Lower Relative to Tomato Paste in Mongolian Gerbils J. Nutr., June 1, 2007; 137(6): 1395 - 1400. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-Q. Hu, C. Liu, H. Ernst, N. I. Krinsky, R. M. Russell, and X.-D. Wang The Biochemical Characterization of Ferret Carotene-9', 10'-Monooxygenase Catalyzing Cleavage of Carotenoids in Vitro and in Vivo J. Biol. Chem., July 14, 2006; 281(28): 19327 - 19338. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Kamangar, G. M. Dores, and W. F. Anderson Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World J. Clin. Oncol., May 10, 2006; 24(14): 2137 - 2150. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Meyerhardt, D. Heseltine, H. Campos, M. D. Holmes, W. C. Willett, E. P. Winer, P. C. Enzinger, C. A. Bunnell, M. H. Kulke, and C. S. Fuchs Assessment of a Dietary Questionnaire in Cancer Patients Receiving Cytotoxic Chemotherapy J. Clin. Oncol., November 20, 2005; 23(33): 8453 - 8460. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Jenab, P. Ferrari, M. Mazuir, A. Tjonneland, F. Clavel-Chapelon, J. Linseisen, A. Trichopoulou, R. Tumino, H. B. Bueno-de-Mesquita, E. Lund, et al. Variations in Lycopene Blood Levels and Tomato Consumption across European Countries Based on the European Prospective Investigation into Cancer and Nutrition (EPIC) Study J. Nutr., August 1, 2005; 135(8): 2032S - 2036S. [Full Text] [PDF]
|
|
|
|
|
|
U. Siler, A. Herzog, V. Spitzer, N. Seifert, A. Denelavas, P. B. Hunziker, L. Barella, W. Hunziker, M. Lein, R. Goralczyk, et al. Lycopene Effects on Rat Normal Prostate and Prostate Tumor Tissue J. Nutr., August 1, 2005; 135(8): 2050S - 2052S. [Full Text] [PDF]
|
|
|
|
|
|
R. B. van Breemen How Do Intermediate Endpoint Markers Respond to Lycopene in Men with Prostate Cancer or Benign Prostate Hyperplasia? J. Nutr., August 1, 2005; 135(8): 2062S - 2064S. [Full Text] [PDF]
|
|
|
|
|
|
E. Reboul, P. Borel, C. Mikail, L. Abou, M. Charbonnier, C. Caris-Veyrat, P. Goupy, H. Portugal, D. Lairon, and M.-J. Amiot Enrichment of Tomato Paste with 6% Tomato Peel Increases Lycopene and {beta}-Carotene Bioavailability in Men J. Nutr., April 1, 2005; 135(4): 790 - 794. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. L. Hantz, L. F. Young, and K. R. Martin Physiologically Attainable Concentrations of Lycopene Induce Mitochondrial Apoptosis in LNCaP Human Prostate Cancer Cells Experimental Biology and Medicine, March 1, 2005; 230(3): 171 - 179. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Tang, T. Jin, X. Zeng, and J.-S. Wang Lycopene Inhibits the Growth of Human Androgen-Independent Prostate Cancer Cells In Vitro and in BALB/c Nude Mice J. Nutr., February 1, 2005; 135(2): 287 - 290. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. R. Taylor and P. Greenwald Nutritional Interventions in Cancer Prevention J. Clin. Oncol., January 10, 2005; 23(2): 333 - 345. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. F. McCarty Targeting Multiple Signaling Pathways as a Strategy for Managing Prostate Cancer: Multifocal Signal Modulation Therapy Integr Cancer Ther, December 1, 2004; 3(4): 349 - 380. [Abstract] [PDF]
|
|
|
|
|
|
P. D. Terry, J. B. Terry, and T. E. Rohan Long-Chain (n-3) Fatty Acid Intake and Risk of Cancers of the Breast and the Prostate: Recent Epidemiological Studies, Biological Mechanisms, and Directions for Future Research J. Nutr., December 1, 2004; 134(12): 3412S - 3420S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Limpens, W. M. van Weerden, K. Kramer, D. Pallapies, U. C. Obermuller-Jevic, and F. H. Schroder Re: Prostate Carcinogenesis in N-methyl-N-nitrosourea (NMU)-Testosterone-Treated Rats Fed Tomato Powder, Lycopene, or Energy-Restricted Diets J Natl Cancer Inst, April 7, 2004; 96(7): 554 - 554. [Full Text] [PDF]
|
|
|
|
|
|
U. C. Obermuller-Jevic, E. Olano-Martin, A. M. Corbacho, J. P. Eiserich, A. van der Vliet, G. Valacchi, C. E. Cross, and L. Packer Lycopene Inhibits the Growth of Normal Human Prostate Epithelial Cells in Vitro J. Nutr., November 1, 2003; 133(11): 3356 - 3360. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Milner Incorporating Basic Nutrition Science into Health Interventions for Cancer Prevention J. Nutr., November 1, 2003; 133(11): 3820S - 3826. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Forbes, K. Gillette, and I. Sehgal Lycopene Increases Urokinase Receptor and Fails to Inhibit Growth or Connexin Expression in a Metastatically Passaged Prostate Cancer Cell Line: A Brief Communication Experimental Biology and Medicine, September 1, 2003; 228(8): 967 - 971. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
